Tags

Type your tag names separated by a space and hit enter

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.
Euro Surveill. 2017 Oct; 22(43)ES

Abstract

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.

Authors+Show Affiliations

Discipline of General Practice, University of Adelaide, Australia. School of Global and Population Health, University of Melbourne, Australia. WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia.Discipline of General Practice, University of Adelaide, Australia.Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia.WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia.Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia.SA Pathology, Adelaide, Australia.WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia.WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia.PathWest Laboratory Medicine WA, Perth, Australia.School of Biomedical Sciences, Monash University, Melbourne, Australia.Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia.Discipline of General Practice, University of Adelaide, Australia.Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. School of Global and Population Health, University of Melbourne, Australia.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29090681

Citation

Sullivan, Sheena G., et al. "Low Interim Influenza Vaccine Effectiveness, Australia, 1 May to 24 September 2017." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 22, no. 43, 2017.
Sullivan SG, Chilver MB, Carville KS, et al. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Euro Surveill. 2017;22(43).
Sullivan, S. G., Chilver, M. B., Carville, K. S., Deng, Y. M., Grant, K. A., Higgins, G., Komadina, N., Leung, V. K., Minney-Smith, C. A., Teng, D., Tran, T., Stocks, N., & Fielding, J. E. (2017). Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 22(43). https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707
Sullivan SG, et al. Low Interim Influenza Vaccine Effectiveness, Australia, 1 May to 24 September 2017. Euro Surveill. 2017;22(43) PubMed PMID: 29090681.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. AU - Sullivan,Sheena G, AU - Chilver,Monique B, AU - Carville,Kylie S, AU - Deng,Yi-Mo, AU - Grant,Kristina A, AU - Higgins,Geoff, AU - Komadina,Naomi, AU - Leung,Vivian Ky, AU - Minney-Smith,Cara A, AU - Teng,Don, AU - Tran,Thomas, AU - Stocks,Nigel, AU - Fielding,James E, PY - 2017/11/2/entrez PY - 2017/11/2/pubmed PY - 2018/4/3/medline KW - Australia KW - epidemiology KW - influenza KW - influenza-like illness - ILI KW - surveillance KW - vaccines and immunisation KW - viral infections JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin JO - Euro Surveill VL - 22 IS - 43 N2 - In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons. SN - 1560-7917 UR - https://www.unboundmedicine.com/medline/citation/29090681/Low_interim_influenza_vaccine_effectiveness_Australia_1_May_to_24_September_2017_ L2 - http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.43.17-00707 DB - PRIME DP - Unbound Medicine ER -